Kaj Anker Jørgensen

2.1k total citations
72 papers, 1.6k citations indexed

About

Kaj Anker Jørgensen is a scholar working on Molecular Biology, Surgery and Transplantation. According to data from OpenAlex, Kaj Anker Jørgensen has authored 72 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Surgery and 15 papers in Transplantation. Recurrent topics in Kaj Anker Jørgensen's work include Renal Transplantation Outcomes and Treatments (14 papers), Signaling Pathways in Disease (10 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Kaj Anker Jørgensen is often cited by papers focused on Renal Transplantation Outcomes and Treatments (14 papers), Signaling Pathways in Disease (10 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Kaj Anker Jørgensen collaborates with scholars based in Denmark, United States and Sweden. Kaj Anker Jørgensen's co-authors include Erik Stoffersen, Erik Berg Schmidt, My Svensson, Jørn Dyerberg, Jeppe Hagstrup Christensen, M. Simonsen, A Gammeltoft, Søren Rittig, Konstantinos Kamperis and T. Arnfred and has published in prestigious journals such as The Journal of Urology, Clinical Chemistry and British Journal Of Nutrition.

In The Last Decade

Kaj Anker Jørgensen

71 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaj Anker Jørgensen Denmark 23 369 315 307 214 209 72 1.6k
Paul F. Williams Australia 29 603 1.6× 131 0.4× 212 0.7× 396 1.9× 622 3.0× 89 2.6k
Vladimı́r Teplan Czechia 22 200 0.5× 159 0.5× 256 0.8× 642 3.0× 138 0.7× 85 1.5k
Yousri M. Barri United States 21 395 1.1× 157 0.5× 150 0.5× 582 2.7× 324 1.6× 35 1.8k
Stefan Reuter Germany 23 424 1.1× 230 0.7× 106 0.3× 394 1.8× 327 1.6× 62 1.9k
Douglas M. Silverstein United States 21 237 0.6× 143 0.5× 132 0.4× 743 3.5× 238 1.1× 50 1.4k
Byung Kee Bang South Korea 30 669 1.8× 332 1.1× 146 0.5× 864 4.0× 431 2.1× 98 2.6k
Gary Chusney United Kingdom 17 332 0.9× 235 0.7× 96 0.3× 205 1.0× 456 2.2× 25 2.5k
A Albertazzi Italy 25 331 0.9× 81 0.3× 196 0.6× 736 3.4× 168 0.8× 107 1.6k
G Keusch Switzerland 25 407 1.1× 73 0.2× 136 0.4× 558 2.6× 211 1.0× 85 2.0k
Susan B. Conley United States 22 314 0.9× 323 1.0× 50 0.2× 231 1.1× 180 0.9× 60 1.3k

Countries citing papers authored by Kaj Anker Jørgensen

Since Specialization
Citations

This map shows the geographic impact of Kaj Anker Jørgensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaj Anker Jørgensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaj Anker Jørgensen more than expected).

Fields of papers citing papers by Kaj Anker Jørgensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaj Anker Jørgensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaj Anker Jørgensen. The network helps show where Kaj Anker Jørgensen may publish in the future.

Co-authorship network of co-authors of Kaj Anker Jørgensen

This figure shows the co-authorship network connecting the top 25 collaborators of Kaj Anker Jørgensen. A scholar is included among the top collaborators of Kaj Anker Jørgensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaj Anker Jørgensen. Kaj Anker Jørgensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jørgensen, Kaj Anker, Ruth Østerby, Steffen E. Petersen, et al.. (2020). Human kidney graft survival correlates with structural parameters in baseline biopsies: a quantitative observational cohort study with more than 14 years’ follow-up. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 478(4). 659–668. 2 indexed citations
3.
Svensson, My, Allan Flyvbjerg, Erik Berg Schmidt, et al.. (2015). n-3 polyunsaturated fatty acids and adiponectin in patients with end-stage renal disease. Clinical Nephrology. 83 (2015)(5). 279–285. 15 indexed citations
4.
Idorn, Thomas, Mads Hornum, Mette Bjerre, et al.. (2012). Plasma adiponectin before and after kidney transplantation. Transplant International. 25(11). 1194–1203. 14 indexed citations
5.
Magnusson, Nils E., Mads Hornum, Kaj Anker Jørgensen, et al.. (2012). Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation. BMC Nephrology. 13(1). 8–8. 34 indexed citations
6.
Svensson, My, et al.. (2011). Marine n-3 fatty acids, atrial fibrillation and QT interval in haemodialysis patients. British Journal Of Nutrition. 107(6). 903–909. 22 indexed citations
7.
Svensson, My, Ole Fröbert, Erik Berg Schmidt, et al.. (2010). The effect of n-3 fatty acids on levels of methylarginines in patients with end-stage renal disease. Journal of Nephrology. 23(4). 459–464. 7 indexed citations
9.
Alstrup, Aage Kristian Olsen, et al.. (2010). Abnormal Diurnal Rhythm of Urine Output Following Renal Transplantation: The Impact of Blood Pressure and Diuretics. Transplantation Proceedings. 42(9). 3529–3536. 13 indexed citations
10.
Hornum, Mads, Kaj Anker Jørgensen, Jesper Melchior Hansen, et al.. (2010). New-Onset Diabetes Mellitus after Kidney Transplantation in Denmark. Clinical Journal of the American Society of Nephrology. 5(4). 709–716. 49 indexed citations
11.
Jørgensen, Kaj Anker, et al.. (2006). Calcineurin Activity in Tacrolimus-Treated Renal Transplant Patients Early After and 5 Years After Transplantation. Transplantation Proceedings. 38(8). 2651–2653. 10 indexed citations
12.
Kamperis, Konstantinos, Søren Rittig, Kaj Anker Jørgensen, & Jens C. Djurhuus. (2006). Nocturnal polyuria in monosymptomatic nocturnal enuresis refractory to desmopressin treatment. American Journal of Physiology-Renal Physiology. 291(6). F1232–F1240. 69 indexed citations
13.
Højskov, Carsten Schriver, et al.. (2005). Role of metabolites and calcineurin inhibition on C2 monitoring in renal transplant patients. Nephrology Dialysis Transplantation. 20(3). 618–621. 11 indexed citations
14.
Povlsen, Johan Vestergaard, et al.. (2003). Comparison of the pharmacokinetics of tacrolimus and cyclosporine at equivalent molecular doses. Transplantation Proceedings. 35(4). 1314–1318. 23 indexed citations
15.
Jørgensen, Kaj Anker, Johan Vestergaard Povlsen, S. Madsen, et al.. (2002). Two-hour blood tacrolimus levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal transplant patients. Transplantation Proceedings. 34(5). 1721–1722. 5 indexed citations
16.
Jørgensen, Kaj Anker, et al.. (1998). Burgen Soy-Lin: development of an innovative functional staple food.. Queensland's institutional digital repository (The University of Queensland). 50(6). 297–299. 3 indexed citations
17.
Birkeland, Sven Arvid, et al.. (1995). Organ donation: number of brain deaths, refusal rate, actual donation, and multiorgan transplantation 1990-1994 in a Danish population of 1 million compared to the whole of Denmark.. PubMed. 27(6). 3521–4. 3 indexed citations
19.
Jørgensen, Kaj Anker & Erik Stoffersen. (1981). Hydrocortisone, Platelet Aggregation and Platelet Prostaglandin Metabolism. Scandinavian Journal of Haematology. 25(5). 445–447. 9 indexed citations
20.
Jørgensen, Kaj Anker, Birgitte Korsager, Gunnar Johannsen, L Freund, & H W Wilkinson. (1981). Legionnaires' Disease Imported to Denmark from Italy. Scandinavian Journal of Infectious Diseases. 13(2). 133–136. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026